References
- Office for Human Research Protection, National Institutes of Health, Letter to Johns Hopkins University School of Medicine et al. on human subjects protection under multiple assurance project assurance act. July 19, 2001. Available at http://ohrp.osophs.dhhs.gov/detrm_letrs/ju10la.pdf. Accessed August 30, 2001.
- Johns Hopkins University response to OHRP suspension of research, July 21, 2001. Available at http://www.sunspot.net/news/health/bal-hopkinsreacts.story. Accessed August 30, 2001.
- , External Review Committee Submits Report, Addendum to Hopkins. Available at http://www.hopkinsmedicine.org/press/2001/august/010829.htm. August 29, 2001. Accessed August 30, 2001.
- Health Canada. Advisory not to use products containing ephedra or ephedrine. June 14, 2001, Available at http://www.hc-c.gc.ca/english/archives/warnings/2001/2001_67e.htm.
- Food and Drug Administration Science Background Safety of Phenylpropan-olamine, November 6, 2000. Available at http://www.fda.gov/cder/drug/infopage/ppa/science.htmx Accessed August 30, 2001.